taurolidine has been researched along with Cancer of Gastrointestinal Tract in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braumann, C; Gutt, CN; Jacobi, CA; Menenakos, C; Mueller, JM; Scheele, J; Willems, W | 1 |
1 trial(s) available for taurolidine and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Taurolidine reduces the tumor stimulating cytokine interleukin-1beta in patients with resectable gastrointestinal cancer: a multicentre prospective randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Interleukin-1beta; Interleukin-6; Male; Middle Aged; Prospective Studies; Taurine; Thiadiazines | 2009 |